Journal Watch · Frontiers in Immunology · 2026

The multifaceted role of NF-κB signaling in psoriasis: from inflammatory amplification to epidermal remodeling.

By framing NF-κB as a networked regulatory hub rather than a linear pathway, this review provides an integrated perspective on psoriasis pathogenesis and highlights opportunities for precision immunomodulation with improved efficacy and safety.

Cao W, Hu X, Wang Y, Wei SFrontiers in Immunology3 min readPharma relevance 50/100

DOI: 10.3389/fimmu.2026.1808775PMID: 42459684Study type: review / perspective

TL;DR

By framing NF-κB as a networked regulatory hub rather than a linear pathway, this review provides an integrated perspective on psoriasis pathogenesis and highlights opportunities for precision immunomodulation with improved efficacy and safety.

Key findings

  • Finally, we discuss therapeutic strategies targeting the NF-κB convergence hub, including upstream sensor antagonism, adaptor-level modulation, multi-target small molecules, natural products, and advanced skin-targeted delivery systems.
  • By framing NF-κB as a networked regulatory hub rather than a linear pathway, this review provides an integrated perspective on psoriasis pathogenesis and highlights opportunities for precision immunomodulation with improved efficacy and safety.

What they did

In this review, we synthesize recent advances demonstrating how innate immune sensors, including nucleic acid-sensing pathways and Toll-like receptors, converge on NF-κB to initiate inflammatory programs, and how adaptive immune circuits-particularly Th17/IL-17 signaling-exploit NF-κB to sustain disease chronicity. We further highlight the active role of keratinocytes as intrinsic amplifiers of inflammation through NF-κB-dependent programs governing hyperproliferation, oxidative stress responses, and secondary cytokine production. Beyond canonical signaling, emerging evidence reveals that non-coding RNAs and epigenetic regulators fine-tune NF-κB activity, shaping transcriptional persistence and inflammatory memory in psoriatic skin.

Full abstract (original)

Background: Psoriasis is a chronic immune-mediated inflammatory skin disease characterized by persistent epidermal hyperplasia and relapsing inflammation. Although extensive progress has been made in elucidating individual pathogenic pathways, a unifying framework that integrates innate immune activation, adaptive immune maintenance, and keratinocyte-driven amplification remains incomplete. Accumulating evidence indicates that nuclear factor-κB (NF-κB) functions as a central convergence hub that coordinates these diverse inflammatory inputs in psoriasis.

What they did: In this review, we synthesize recent advances demonstrating how innate immune sensors, including nucleic acid-sensing pathways and Toll-like receptors, converge on NF-κB to initiate inflammatory programs, and how adaptive immune circuits-particularly Th17/IL-17 signaling-exploit NF-κB to sustain disease chronicity. We further highlight the active role of keratinocytes as intrinsic amplifiers of inflammation through NF-κB-dependent programs governing hyperproliferation, oxidative stress responses, and secondary cytokine production. Beyond canonical signaling, emerging evidence reveals that non-coding RNAs and epigenetic regulators fine-tune NF-κB activity, shaping transcriptional persistence and inflammatory memory in psoriatic skin.

Results & conclusions: Finally, we discuss therapeutic strategies targeting the NF-κB convergence hub, including upstream sensor antagonism, adaptor-level modulation, multi-target small molecules, natural products, and advanced skin-targeted delivery systems. By framing NF-κB as a networked regulatory hub rather than a linear pathway, this review provides an integrated perspective on psoriasis pathogenesis and highlights opportunities for precision immunomodulation with improved efficacy and safety.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1808775 · PubMed 42459684.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

By framing NF-κB as a networked regulatory hub rather than a linear pathway, this review provides an integrated perspective on psoriasis pathogenesis and highlights opportunities for precision immunomodulation with improved efficacy and safety.

What type of study is this?

It is a review / perspective, published in Frontiers in Immunology in 2026. In this review, we synthesize recent advances demonstrating how innate immune sensors, including nucleic acid-sensing pathways and Toll-like receptors, converge on NF-κB to initiate inflammatory programs, and how adaptive immune circuits-particularly Th17/IL-17 signaling-exploit NF-κB to sustain disease chronicity.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1808775. PubMed ID: 42459684. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Cao W, Hu X, Wang Y, Wei S. The multifaceted role of NF-κB signaling in psoriasis: from inflammatory amplification to epidermal remodeling.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1808775.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/the-multifaceted-role-of-nf-b-signaling-in-psoriasis-from-inflammatory-a-808775/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides